Acromegaly screening

Acromegaly Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Acromegaly from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Radiation Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Acromegaly screening On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Acromegaly screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Acromegaly screening
CDC on Acromegaly screening
Acromegaly screening in the news
Blogs on Acromegaly screening
Directions to Hospitals Treating Acromegaly
Risk calculators and risk factors for Acromegaly screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Screening

• According to the endocrine society, screening for acromegaly by measurement of IGF-1 is recommended among patients with the clinical features of acromegaly. These features include the following:
  • Enlarged hands and feet
  • Change in the facial features
  • Headache
  • Increase sweating
  • Paraesthesia
  • Skin thickening
  • Protrusion of the lower jaw
• Screening also is recommended in patients with associated conditions of acromegaly. Acromegaly is associated with different comorbidities so that screening is important in patients with these comorbidities which include:
  • Diabetes Mellitus
  • Carpal tunnel syndrome
  • Arthritis
  • Sleep apnea
  • Hypertension